Scipher Medicine rakes in $30 mln Series B

Scipher Medicine, a developer of a molecular technology platform, has raised $30 million in Series B financing.

Scipher Medicine, a developer of a molecular technology platform, has raised $30 million in Series B financing. Northpond Ventures led the round with participation from other investors that included Alumni Ventures Group, Tachyon Ventures, Khosla Ventures and Granpool Innovative Investments.

Source: Press Release